Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1925 of 3330
Next
>>
>
48101 to 48125 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
184A1	NM	Basal	MG-132	Proteasome	Proteasome	0.00427	uM	12509.17	1.0198	1.0283	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	0.00427	uM	12509.17	1.0198	1.0283	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	0.0213	uM	12509.17	0.5438	0.2925	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	0.0213	uM	12509.17	0.5438	0.2925	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	0.107	uM	12509.17	0.3961	0.0299	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	0.107	uM	12509.17	0.3961	0.0299	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	0.533	uM	12509.17	0.1760	-0.4241	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	0.533	uM	12509.17	0.1760	-0.4241	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	2.67	uM	12509.17	0.0354	-0.8176	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	2.67	uM	12509.17	0.0354	-0.8176	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	13.3	uM	12509.17	0.0379	-0.8085	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	13.3	uM	12509.17	0.0379	-0.8085	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	66.7	uM	12509.17	0.2094	-0.3476	1.3955
184A1	NM	Basal	MG-132	Proteasome	Proteasome	66.7	uM	12509.17	0.2094	-0.3476	1.3955
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.000171	uM	12566.17	1.0051	1.0069	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.000171	uM	12566.17	1.0051	1.0069	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.000853	uM	12566.17	0.9407	0.9182	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.000853	uM	12566.17	0.9407	0.9182	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.00427	uM	12566.17	0.9924	0.9896	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.00427	uM	12566.17	0.9924	0.9896	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.0213	uM	12566.17	0.5454	0.3221	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.0213	uM	12566.17	0.5454	0.3221	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.107	uM	12566.17	0.2916	-0.1378	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.107	uM	12566.17	0.2916	-0.1378	1.4648
184B5	NM	Basal	MG-132	Proteasome	Proteasome	0.533	uM	12566.17	0.1567	-0.4356	1.4648

|<
<<
Previous
Page 1925 of 3330
Next
>>
>
48101 to 48125 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)